Sign in
Create a Profile
Specialized Treatment Early in Psychosis (STEP)
Diseases and Conditions Researched
Schizophrenia and Disorders With Psychotic Features
What is the purpose of this trial?
The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic and psychosocial treatments will be delivered within a state public mental health center.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsor: | Yale University |
|---|---|
| Dates: | March 29, 2006 |
| Last Updated: | July 7, 2010 |
| Study HIC#: | 0601001013 |
| Clinicaltrials.gov ID: | NCT00309452 |
How will my information be used?
For more information about this trial, contact:
Scott Woods, M.D.
(203) 974-7300
scott.woods@yale.edu
Vinod Srihari, MD
(203) 974-7816
vinod.srihari@yale.edu
Principal Investigator
Srihari, Vinod H.
Psychiatry
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
